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Satellite cells are myogenic precursors responsible for skeletal muscle regeneration. Satellite cells are absent in the Pax-7/ mouse,
suggesting that this transcription factor is crucial for satellite cell specification [Seale, P., Sabourin, L.A., Girgis-Gabardo, A., Mansouri, A.,
Gruss, P., Rudnicki, M.A., 2000. Pax7 is required for the specification of myogenic satellite cells. Cell 102, 777–786]. Analysis of Pax-7
expression in activated satellite cells unexpectedly revealed substantial heterogeneity within individual clones. Further analyses show that
Pax-7 and myogenin expression are mutually exclusive during differentiation, where Pax-7 appears to be up-regulated in cells that escape
differentiation and exit the cell cycle, suggesting a regulatory relationship between these two transcription factors. Indeed, overexpression of
Pax-7 down-regulates MyoD, prevents myogenin induction, and blocks MyoD-induced myogenic conversion of 10T1/2 cells.
Overexpression of Pax-7 also promotes cell cycle exit even in proliferation conditions. Together, these results suggest that Pax-7 may
play a crucial role in allowing activated satellite cells to reacquire a quiescent, undifferentiated state. These data support the concept that
satellite cell self-renewal may be a primary mechanism for replenishment of the satellite cell compartment during skeletal muscle
regeneration.
D 2004 Elsevier Inc. All rights reserved.
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Adult skeletal muscle tissue possesses a tremendous
capacity for regeneration in response to acute injury or
chronic disease. Because the nuclei within skeletal muscle
fibers are terminally differentiated and thus thought to be
incapable of participating in muscle repair, these responses
are largely attributed to a distinct and small population of
myogenic progenitors that are resident in adult skeletal
muscle, called satellite cells (Hawke and Garry, 2001;
Schultz and McCormick, 1994; Smith et al., 1994). This cell
population is physically distinct from the adult myofiber as
they reside between the sarcolemma and the basal lamina in0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: Bradley.Olwin@colorado.edu (B.B. Olwin).a nonproliferative, quiescent state (Mauro, 1961; Schultz
et al., 1978). Upon stimuli such as muscle injury, satellite
cells become activated, proliferate extensively and ulti-
mately, fuse with existing fibers, or fuse together to form
new myofibers (Hawke and Garry, 2001; Schultz and
McCormick, 1994; Smith et al., 1994). A critical aspect of
muscle tissue regeneration is the replenishment of the
satellite cell population, originally proposed to occur via
self-renewal (Angello and Hauschka, 1996; Baroffio et al.,
1996; Schultz et al., 1986). Recently, the capacity for
satellite cell self-renewal and the lineal origin of the satellite
cell population has been questioned and generated consi-
derable controversy (Ferrari et al., 1998; Hawke and Garry,
2001; Seale and Rudnicki, 2000).
The developmental origin of satellite cells remains
unclear, as do the molecular mechanisms responsible for
maintaining the satellite cell population. The lack of satellite
cells in the newborn Pax-7 null mouse suggests that this275 (2004) 375–388
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biogenesis (Seale et al., 2000). Although Pax-7/ mice
lack satellite cells in all the skeletal muscle groups
examined, there appear to be no major structural or
patterning defects in the differentiated muscle (Seale et al.,
2000). Despite these extensive descriptive analyses of the
Pax-7/ mouse, there is no detailed information on the
behavior of Pax-7 protein in activated and proliferating
satellite cells. More importantly, little is known regarding
potential regulatory interactions between Pax-7 and the
MyoD transcription factor family. In differentiating cultures
of human fetal myoblasts, Pax-7 is co-expressed with MyoD
and myf-5, but is not present in cells expressing myogenin
(Reimann et al., 2004). Similarly, ectopic expression of Pax-
7 in 10T1/2 cells fails to induce myogenin, yet ectopic
expression of Pax-7 in skeletal muscle side population cells
that are CD45+/Sca1+ induces the myogenic program (Seale
et al., 2004). Thus, it appears that Pax-7 may regulate
myogenesis via the MyoD family of transcription factors.
To further clarify a role for Pax-7 in satellite cells, we
examined the timing and distribution of Pax-7 protein
expression in satellite cells on isolated adult muscle fibers,
primary satellite cell-derived clonal cultures and satellite
cell-derived cell lines. We found that: (1) Pax-7 is differ-
entially expressed in satellite cells as well as in satellite cell
progeny; (2) Pax-7 and myogenin expression are mutually
exclusive in differentiating adult myoblasts; and (3) Pax-7 is
up-regulated in a small population of cells that exit the cell
cycle, yet escape differentiation, potentially representing a
self-renewing satellite cell. In support of this idea, we show
that overexpressed Pax-7 interferes with MyoD-dependent
transcriptional activation, down-regulates MyoD expression,
and prevents myogenin induction. Overexpression of Pax-7
also induces cell cycle exit even under growth conditions.
The loss of MyoD protein, interruption of MyoD function,
and exit from the cell cycle induce a mitotically quiescent
state in cultured satellite cells qualitatively similar to that of
quiescent satellite cells in vivo. Thus, our data supports a
model whereby Pax-7 is required for acquisition of the
satellite cell phenotype; this is consistent with the apparent
loss of satellite cells seen in Pax-7/ muscle tissue and
suggests that satellite cells are capable of self-renewal.Materials and methods
Primary cultures
Adult primary myoblasts were obtained from hind limb
muscles of 10–20-week-old B6D2F1 mice. Briefly, dissected
muscle was digested with collagenase type I (Worthington)
for approximately 1 h. A single cell suspension was obtained
after filtering the samples through a 70-Am mesh (Falcon).
For clonal cultures, approximately 500 cells/cm2 were plated
on collagen coated-dishes and cultured for 48 h in F12-C
supplemented with 15% horse serum and 1 nM FGF-2, at378C and 5% CO2. Differentiation was induced by incubat-
ing the cultures in F12-C supplemented with 2% horse serum
and 60 Ag/ml insulin. When required, 10 AM BrdU was
added for 1 h before fixation.
Muscle fiber cultures
Myofibers and their associated satellite cells were
prepared as described previously (Cornelison and Wold,
1997), with some modifications. Briefly, muscle was
dissected from adult mouse hind limbs and digested with
collagenase type I (Worthington) for approximately 45 min
to yield single intact fibers that were either fixed or cultured
in F12-C supplemented with 15% horse serum and 1 nM
FGF-2, for 48 h. When required, 10 AM BrdU was added
for 2 h before fixation.
Cell lines
MM14 and C2C12 myoblasts were plated at 100–500
cells/cm2 and cultured for 24 h (F12-C, 15% horse serum,
500 pM FGF-2; for MM14 and DMEM/F12, 10% FBS; for
C2C12), at 378C and 5% CO2. When required, 10 AM BrdU
was added for 1 h before fixation. C2C12 cultures were
induced to differentiate in DMEM/F12, 5% horse serum at
378C and 5% CO2 for at least 48 h. When required, MM14
and C2C12 cells were induced to differentiate in the
presence of 0.1 mM 1-h-d-arabinofuranosylcytosine (araC,
Sigma), starting at 48 h after induction for a period of 24 h
and 6 days, respectively. 10T1/2 cells were cultured in
DMEM, 10% FBS, at 378C and 5% CO2. In myogenic
conversion assays, cultures were induced to differentiate in
DMEM, 2% FBS for 48 h.
Pax7 overexpression and knockdown
pcDNA3-Pax-7d (1.5 Ag/well; kindly provided by Dr. M.
Rudnicki) per well, was used to overexpress Pax-7 in
MM14 and adult primary myoblasts, cultured in six-well
plates (Corning), using the Lipofectamine 2000 transfection
reagent (Invitrogen), following manufacturer’s instructions.
Staining and BrdU incorporation were done at 24 and 48 h
after transfection, as described above. For Pax-7 knockdown
experiments, 200 nM custom siRNA duplexes (Dharmacon,
kindly provided by Dr. X. Liu) were transfected in MM14
cells (or 10T1/2 cells, when required) using the Trans-
messenger transfection reagent (Qiagen), following manu-
facturer’s instructions. The target sequences in Pax-7
mRNA were CCACATCCGTCACAAGATA (D1); GAAT-
CAAGTTCGGGAAGAA (D2); CAAGATTCTGTGCC-
GATA (D3); and CATGAACCCTGTCAGCAAT (D4).
Firefly Luciferase targeting siRNA (Dharmacon, kindly
provided by Dr. X. Liu) was used as a negative control (ctrl:
AGACGATGACGGAAAAAGA). Staining or whole cell
lysates were performed 48 or 72 h after transfection, when
required.
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Myogenic conversion was induced in 10T1/2 cells by
transfecting (Lipofectamine 2000, Invitrogen) 1 Ag per well
of the pRSV-MyoD expression vector, and 24 h after
transfection, cells were induced to differentiate. Myogenic
conversion was scored after 48 h of differentiation by
quantifying myogenin staining. Transfection efficiency was
quantified by counting all myogenin- and Pax7-positive cells
per field. When required, 0.5, 1, 1.5, or 2 Ag of pcDNA-Pax-
7 vector was co-transfected along with 1 Ag of MyoD or
MyoDE47 (kindly provided by Dr. S. Tapscott) expression
vectors. When required, pcDNA3 vector was used as carrier
DNA to transfect 2 Ag of total DNA in every case. As a
measure of MyoD transcriptional activity, 1 Ag per well of
the 4Rtk-luc reporter was transfected in the absence or the
presence of 0.4 Ag of pRSV-MyoD and in the absence or
presence of 0.2, 0.4, or 0.8 Ag of pcDNA-Pax-7. The CMV-
LacZ expression vector (0.025 Ag) was co-transfected to
normalize for transfection efficiency. A total amount of 2.5
Ag of DNA was transfected for each well, using an empty
pcDNA3 plasmid as carrier when required. After inducing
differentiation for 48 h, whole cell lysates were collected and
luciferase and h-galactosidase activities determined using
the Dual-Light System (Applied Biosystems), following
manufacturer’s instructions.
Immunofluorescence
Primary myoblasts, isolated fibers, and cultured cells were
fixed in 4% paraformaldehyde for 20min. Primary antibodies
and dilutions used were as follows: Mouse monoclonal anti-
Pax7 (Hybridoma Bank, Iowa University) at 1:5 (cell culture
supernatant); mouse monoclonal anti-BrdU (BMB) at 1:10
(cell culture supernatant); chick polyclonal anti-syndecan-4
extracellular domain (Cornelison et al., in press) at 1:1000;
rabbit polyclonal anti-MyoD (Santa Cruz) at 1:30; rabbit
polyclonal anti-myogenin (Santa Cruz) at 1:30; rabbit
polyclonal anti-c-met (Santa Cruz) at 1:30. When the rabbit
polyclonal anti-myogenin (Santa Cruz) was used, low levels
of perinuclear staining were observed in all nondifferentiated
myoblasts. This staining was not detected when using a
monoclonal antimyogenin antibody (F5D, Hybridoma
Bank); it was also absent in all nonmyogenic cells (data not
shown). Both antibodies stained the cell nucleus of differ-
entiating myogenic cells. InWestern blots, the two antibodies
recognized indistinguishable patterns of proteins (data not
shown). The polyclonal myogenin antibody was used to
allow co-staining of myogenin and Pax-7 within a single cell.
Secondary antibodies were conjugated with Alexa 594,
Alexa 488, Cascade Blue (Molecular Probes) or AMCA
(Jackson ImmunoResearch). Vectashield (Vector Laborato-
ries) was used as mounting media in every case. When the
anti-syndecan-4 antibody was used on fibers, a specific
blocking step was perform with Blokhen II (Aves Labs) at
1:10 for 1 h before blocking with 5% horse serum for doublelabeling. For BrdU detection, a DNA denaturation step was
included by incubating cell cultures or fibers in 2 N HCl for 1
h or 4 N HCl for 30 min, respectively, at room temperature
before antibody incubations.
Micrographs were taken from a Nikon (Eclipse E800)
epifluorescence microscope, using Slidebook v3.0 acquisi-
tion software (Intelligent Imaging Innovations Inc.) coupled
to a Cooke Sensicam digital camera. Digital deconvolution
for single plane images (no neighbors) was applied to
acquired images (Slidebook v3.0) before figure preparation.
Western blotting
Whole 10T1/2 cell extracts were obtained by incubating
cells in 300–500 Al of Passive Lysis Buffer (Promega), for 15
min at room temperature. Lysates were cleared by spinning at
13,000 rpm for 10 min, at 48C. Total protein (30–50 Ag) was
loaded onto 8% SDS-PAGE gels and transferred onto PVDF
membranes (Millipore) for Western blotting. Primary anti-
bodies and dilutions used were monoclonal anti-MyoD1
(NCL, Novocastra), at 1:100; monoclonal anti-Pax-7
(Hybridoma Bank, Iowa University), at 1:10 (cell culture
supernatant); monoclonal anti-aTubulin (DM1A, Sigma), at
1:100. Anti-mouse or anti-rabbit HRP conjugated secondary
antibodies (Promega) were used at 1:5000 and HRP activity
was visualized using the Western Lightning chemilumines-
cence system (PerkinElmer).Results
Pax-7 is differentially expressed in mouse satellite cells and
mouse satellite cell-derived cell lines
Pax-7 is reported to be essential for muscle satellite cell
specification in mice (Seale et al., 2000), yet the molecular
mechanisms involved are unclear. To gain a better under-
standing of the Pax-7 requirement for satellite cell specifi-
cation, we first studied the appearance and subcellular
localization of Pax-7 protein in satellite cells on intact
myofibers. Surprisingly, an examination of Pax-7 expression
by immunofluorescence showed substantial heterogeneity in
Pax-7 levels, with Pax-7 protein undetectable in 30% of
satellite cells associated with freshly harvested myofibers
(Fig. 1A). This unexpected result suggests that Pax-7 may
not be a universal marker for satellite cells, and raises the
possibility that the requirement of Pax-7 for satellite cell
specification may be transient. Although Pax-7 was not
present in all satellite cells (identified by syndecan-4
immunofluorescence), Pax-7 protein expression was
restricted to this subset of cells and not present in other cell
types within the muscle (data not shown). Heterogeneous
Pax-7 expression persisted after 48 h of myofiber culture
(Fig. 1B, compare upper and middle panels). Furthermore,
this heterogeneity was also detected within daughter cells of
the same clone (Fig. 1B, lower panel), strongly suggesting
Fig. 1. Pax-7 is differentially expressed within clones of activated satellite cells on myofiber cultures. (A) Satellite cells marked by syndecan-4 (Syn-4) on
myofibers fixed immediately after isolation (see Materials and methods). While a large percentage of the syndecan-4-positive cells were also Pax-7-positive
(yellow arrows, upper panel), up to 30% of the satellite cells show no detectable levels of Pax-7 protein (white arrows, lower panel). (B) Clones of activated
satellite cells on 48 h myofiber cultures possess both Pax-7 positive (yellow arrows, upper panel) and Pax-7-negative (white arrows, middle panel) cell
doublets. Differential Pax-7 expression is present within a single clone of activated satellite cells (yellow arrow vs. white arrows, lower panel); only one cell
expresses detectable levels of Pax-7 in a three-cell clone (arrows). (C) The levels of Pax-7 protein exhibit clonal variation (upper panel vs. lower panel) as well
as variation within a single clone (white vs. yellow arrows, lower panel), while MyoD levels are constant. Pax-7-positive satellite cells are indicated by yellow
arrows and Pax-7 low or negative satellite cells are indicated by white arrows. Scale bar = 18 Am.
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cells. The heterogeneity observed for Pax-7 does not
correlate with detectable differences in MyoD staining early
after activation (Fig. 1C), where MyoD staining within a
clone of satellite cells is uniform and Pax-7 staining is highly
heterogeneous.
To assess a role for Pax-7 in satellite cells, we
established dispersed cultures of satellite cells and askedif heterogeneity in Pax-7 protein levels was maintained in
the absence of the myofiber. Primary satellite cells from an
adult mouse were plated at clonal density and cultured for
48 h. Clonal cultures of satellite cells remain syndecan-4-
positive (Fig. 2A), and, in agreement with the observations
from isolated fibers, heterogeneity in the levels of Pax-7
protein detected by immunofluorescence is also present
(Fig. 2A). These results confirm that differential Pax-7
Fig. 2. Differential Pax-7 expression in satellite cell cultures and myoblast cell lines. (A) Clonal primary cultures of satellite cells (sc) express the satellite cell
marker syndecan-4 and are heterogeneous for Pax-7 (yellow vs. white arrows, upper panel). Levels of MyoD protein are constant while Pax-7 levels appear
heterogeneous both between clones and within individual clones (yellow vs. white arrows, lower panel). (B) Pax-7 levels in clonal MM14 cultures are
homogeneous and correlate with both MyoD and syndecan-4 staining. However, clonal C2C12 cultures are highly heterogeneous for both Pax-7 (yellow vs.
white arrows) and MyoD protein levels, while syndecan-4 staining remains relatively constant. Scale bar = 12 Am.
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culture.
We then compared Pax-7 expression in two commonly
used mouse adult myoblast cell lines (MM14 and C2C12).
Consistent with the results observed in myofiber cultures
and in primary satellite cell cultures, C2C12 cells are highly
heterogeneous for Pax-7 and include a substantial number of
cells that do not express detectable Pax-7 protein (Fig. 2B).
In contrast, clonal cultures of MM14 myoblasts are
homogeneous for both Pax-7 and MyoD (Fig. 2B).
Quantification of Pax-7 and MyoD expression in clonal
cultures further illustrates the differences between C2C12
and MM14 cells: 39 F 14% of C2C12 cells are Pax-7-
positive and 48 F 16% are MyoD-positive out of 212 cells
counted, while 95 F 2% of MM14 cells are MyoD-positiveand 98.7 F 2.3% are Pax-7-positive out of 167 cells
counted. Because the presence or absence of MyoD does not
appear to correlate with heterogeneous levels of Pax-7
protein in proliferating myoblasts, we asked if myoblasts
committed to differentiate and thus expressing myogenin
maintained heterogeneous levels of Pax-7 protein.
Pax-7 is lost from differentiating cells and up-regulated in
myoblasts that escape muscle differentiation
When clonal cultures of satellite cells are induced to
differentiate, myogenin is rapidly up-regulated (Fig. 3A).
Notably, Pax-7 staining is not detectable in cells that are
positive for myogenin staining, suggesting that the
presence of both proteins may be mutually exclusive
Fig. 3. Pax-7 and myogenin expression patterns are mutually exclusive in adult satellite cell cultures. (A) Pax-7-positive satellite cells (sc) do not express
myogenin after 48 h in differentiation media (yellow arrows), while those that do not express Pax-7 are myogenin-positive (white arrows). Scale bar = 12 Am.
(B) An up-regulation of Pax-7 staining was observed when clonal C2C12 cultures where induced to differentiate for 2 days (upper panel) and sustained after 4
days (lower panel). Note that Pax-7 and myogenin expression remain mutually exclusive and cells not committed to differentiate (myogenin-negative) are
expressing Pax-7 (Insets). Scale bar = 24 Am.
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(data not shown). Loss of Pax-7 protein appears to be
established early in differentiation-committed cells before
cell alignment or cell fusion takes place. Although Pax-7
and myogenin are also mutually exclusive in C2C12 clonal
cultures, we observed a subpopulation of mononuclear
cells with up-regulated Pax-7 (Fig. 3B). Surprisingly, in
contrast to what was observed in proliferating cultures,
clones of differentiating C2C12 cells do exhibit a
consistent Pax-7-dependent characteristic: All myogenin-
positive cells are Pax-7 negative, while all cells not
expressing myogenin appear to be Pax-7 positive (Fig.
3B, 2 days differentiation). As differentiation proceeds,
these expression patterns are maintained (Fig. 3B, 4 days
differentiation). Intriguingly, in clonal cultures, we
observed a gradient of Pax-7 expression that was high
near differentiation foci (myogenin-positive), and low in
peripheral cells located at the edges of the clones (Fig. 3B).
These differences were evident early during differentiation
(Fig. 3B, 2 days) and maintained later as cell fusion
proceeded (Fig. 3B, 4 days). Interestingly, a similar
increase in Pax-7 expression has been documented during
differentiation of human myoblasts (Reimann et al., 2004).
Together, these results highlight the mutual exclusivity
between Pax-7 and myogenin expression, a phenomenon
that appears to be established early during cell diffe-
rentiation. The up-regulation of Pax-7 protein in cells that
do not appear to be committed to terminal differentiation
raises the possibility that dynamic regulation of Pax-7 may
play a role in maintaining a population of myoblasts that
appear to arise via self-renewal. Highly resembling the
breserve populationQ described for C2C12 cells (Yoshida etal., 1998), these cells may remain capable of additional
expansion and differentiation.
Pax-7 overexpression causes MyoD down-regulation,
prevents myogenin induction, and induces cell cycle exit
To directly test whether Pax-7 is involved in maintaining
a potentially self-renewing myoblast population, we asked if
overexpression of Pax-7 would alter the expression of the
MyoD family of transcription factors, which are not
detectably expressed in satellite cells until 3–12 h following
satellite cell activation (Cornelison and Wold, 1997). Over-
expression of Pax-7 greatly reduced or eliminated MyoD
protein as determined by immunofluorescence in cultured
satellite cells and in MM14 cultures (Fig. 4A). The
endogenous Pax-7 protein (untransfected cells) is not
detectable due to the short exposure times used for detection
of overexpressed Pax-7 (Fig. 4A, Pax-7-negative cells). Of
452 Pax-7-positive satellite cells counted, 91 F 2% were
negative for MyoD. Both MM14 cells and satellite cells
exhibited similar staining patterns. Furthermore, we could
not detect nuclear myogenin protein in Pax-7-positive
transfected cells induced to differentiate for 24 h (Fig. 4B).
Of 231 cells counted in two independent experiments, 99.9
F 0.2% of cells overexpressing Pax-7 were negative for
nuclear myogenin staining.
Pax-7-mediated down-regulation of MyoD and myogenin
protein suggests that Pax-7 may act to inhibit MyoD function
in myoblasts. To directly test this possibility, we asked if
ectopic expression of Pax-7 would prevent MyoD-induced
myogenic conversion of 10T1/2 cells. Transfection of 10T1/
2 cells with a MyoD expression vector efficiently converts
Fig. 4. Pax-7 overexpression down regulates MyoD and myogenin. (A) MM14 cells and mouse satellite cells (sc) were transfected with a Pax-7 expression
vector. Proliferating cells were fixed 24 h after the transfection and stained for MyoD and Pax-7. Cells overexpressing Pax-7 (yellow arrowheads) exhibited low
or undetectable MyoD staining. The exposures selected for visualizing ectopic Pax-7 protein precluded detection of endogenous Pax-7. (B) MM14 cells and
satellite cells (sc) were transfected and grown as described for A, induced to differentiate for 24 h, and then fixed and stained for Pax-7 and myogenin proteins.
Under these conditions, nuclear myogenin is not detectable in Pax-7-overexpressing cells. Although we observe low levels of perinuclear myogenin staining,
this is present in all undifferentiated myogenic cells used in this study and is specific for the Santa Cruz polyclonal antibody utilized (see Materials and
methods). Scale bar = 12 Am.
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transfection efficiency; Fig. 5A) as determined by the
presence of myogenin protein 72 h after transfection.
Inclusion of increasing levels of a Pax-7 expression vector
caused a dose-dependent decrease in the MyoD-dependent
conversion of 10T1/2 cells (Fig. 5A). The loss of myogenic
conversion cannot be attributed to a decrease in MyoD
protein in co-transfected cells, as MyoD expression remained
similar regardless of the amount of Pax-7 present (Fig. 5A).
The decrease in myogenic conversion is also unlikely to arise
from a loss of cells because the percentage of transfected
cells was similar under all conditions (Fig. 5A). To determine
if Pax-7 was acting at the level of muscle gene transcription
or later in myogenic differentiation, we assayed for
expression from a MyoD reporter containing four tandem
E-box (MyoD binding site) repeats driving the luciferase
reporter (4Rtk-luc) (Weintraub et al., 1990) as a function of
the level of Pax-7. When the ratio of the Pax-7 to MyoD
expression vectors was 1:2, the relative activity of the
reporter was similar to MyoD alone (Fig 5B). Increasing the
ratio of Pax-7 to MyoD to 2:1 reduced reporter activity to
background levels (Fig. 5B). Together, these data suggest
that ectopic expression of Pax-7 interferes with MyoD
function and the ability of MyoD to induce muscle-specific
gene expression. A number of mechanisms could be
postulated to account for this. One possibility would be that
Pax-7 alters subcellular localization of MyoD protein. Whenco-transfected cells were stained for MyoD and Pax-7, we
found that MyoD remained localized to the nucleus even in
cells transfected with the highest amount of Pax-7 expression
plasmid (Fig. 5C). Thus, we suggest that a more likely
mechanism for the inhibition of MyoD function by high
levels of Pax-7 involves the interference with MyoD-
dependent muscle gene transcription. Inhibition of MyoD-
dependent transcription could occur either by interference
with the function of the MyoD protein or directly by
competition for MyoD DNA binding sites. To distinguish
between these mechanisms, we asked if Pax-7 could over-
come the effect of a tethered MyoD-E47 dimer. Co-
expression of MyoDE47 alone or at a 1:1 or 1:2 ratio of the
Pax-7 expression plasmid into 10T1/2 cells resulted in
myogenic conversions that were indistinguishable (Fig. 5D).
Thus, Pax-7 does not appear to be capable of overcoming
MyoDE47-induced myogenic conversion, suggesting that
Pax-7 indirectly inhibits wild-type MyoD function.
The highest levels of endogenous Pax-7 were observed in
small numbers of mononuclear cells retained in C2C12 and
satellite cells cultures that had been induced to differentiate.
Because these cultures are maintained in low serum, we
predicted that the cells with high Pax-7 levels might be
quiescent and in a G0 state. To test if high levels of Pax-7 are
associated with cell cycle withdrawal, we performed a short
BrdU pulse in asynchronously cycling MM14 cells that were
transfected with a Pax-7 expression vector. We chose to test
Fig. 5. Pax-7 expression represses MyoD-induced myogenic conversion in 10T1/2 cells by affecting MyoD-dependent transcription. (A) Upper panel: 10T1/2
cells were transfected with a constant amount of a MyoD expression vector in the absence or presence of increasing amounts of a Pax-7 expression vector (see
Materials and methods). Myogenic conversion was scored as the percentage of cells expressing nuclear myogenin (bars, left axis). Transfection efficiency is
represented as the sum of the myogenin and Pax-7-positive cells in each experimental group (black circles, right axis). Lower panel: Western blot analyses of
MyoD protein and tubulin protein (control) for each experimental group at 24 h posttransfection. (B) MyoD transcriptional activity (measured using the 4Rtk-
luc reporter) is repressed by Pax-7 in a dose-dependent fashion. Values were normalized to the reporter induction in the presence of MyoD alone. (C) MyoD
remains localized to the cell nucleus in the absence of Pax-7 (white arrowheads) and at low or high levels of ectopic Pax-7 protein (yellow arrowheads). MyoD
and Pax-7 expression vectors were transfected into 10T1/2 cells as described in A and cells stained for MyoD and Pax-7 proteins. (D) Myogenin is expressed in
10T1/2 cells co-transfected with Pax-7 and a MyoD-E47 (MyoDE47) tethered dimer (lower panel, yellow arrowheads) even at the higher concentrations of
Pax-7 (upper panel, yellow arrowheads) where no myogenin is expressed in control cells co-transfected with MyoD. The MyoD to Pax-7 ratio (1:2) utilized
was already shown to dramatically reduce the overall myogenic conversion of 10T1/2 cells (A) and MyoD-dependent transcription (B). Quantification of
myogenic conversion shows 14.6 F 0.9% of myogenin-expressing cells in the presence of the MyoDE37dimer alone and 11.9 F 0.7% for MyoDE47/Pax-7 at
1:1 and 9.4 F 1% for MyoDE47/Pax-7 at 1:2, respectively. Scale bar = 15 Am.
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since proliferating MM14 cells express relatively uniform
levels of Pax-7 protein (see Fig. 2). In asynchronously
cycling MM14 cells, a 1 h BrdU pulse before fixation yields
readily visible incorporation into the DNA and labels the
expected approximately 50% of the population (Figs. 6A,B).However, transfected cells overexpressing Pax-7 protein do
not detectably incorporate BrdU (Fig. 6A). Lack of BrdU
incorporation was not associated with cell toxicity and
programmed cell death (data not shown). Quantification
reveals at least an 80% reduction in BrdU incorporation
when compared to mock-transfected control cells (Fig. 6B).
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cell cycle exit without commitment to differentiation. To
provide a more stringent test of this observation and an
independent confirmation of these results, we treated differ-
entiated MM14 and C2C12 cultures with 1-h-d-arabinofur-
anosylcytosine (araC) to eliminate any cycling cells from the
population. Typically, this approach is used to enrich C2C12
cultures for myotubes and eliminate bdifferentiation-
defectiveQ cells (Hinterberger and Barald, 1990). Following
araC treatment for 72 h in MM14 cells and 6 days in C2C12
cultures, the cells were fixed and stained for myogenin and
Pax-7 proteins. Upon araC treatment, we observed three
categories of cell types ordered on their relative representa-
tion in the cultures: (1) terminally differentiated cells fused
into myotubes that are myogenin positive and Pax-7
negative; (2) mononuclear differentiated cells that are
myogenin-positive and Pax-7-negative; and (3) mononuclear
cells with undetectable myogenin levels and high levels of
Pax-7 (Fig. 6C). Thus, in myogenic cell lines, quiescent,
undifferentiated cells appear to be uniquely marked with
high levels of Pax-7 expression, consistent with a role for
Pax-7 in exit from the cell cycle without commitment to
terminal differentiation.
If these observations are indicative of the behavior of
satellite cells in vivo, we predict that overexpression of Pax-7
in satellite cells on intact myofibers would down-regulate
MyoD protein and prevent proliferation. Consistent with this
hypothesis, we find that satellite cells on intact myofibers
transfected with a Pax-7 expression vector do not detectably
express MyoD (Fig 6D, upper panels), whereas those
transfected with a control vector are MyoD-positive (Fig
6D, lower panels). Moreover, while control satellite cells
cultured on intact myofibers for 72 h typically undergo two
cell divisions and appear in clones (Cornelison and Wold,
1997; Cornelison et al., 2000, 2001), satellite cells trans-
fected with the Pax-7 plasmid always occur as single cells
(Fig. 6D), suggesting that these cells do not proliferate. We
were unable to obtain sufficient numbers of transfected
satellite cells for statistical analysis due to the extremely low
efficiency of transfection (V 2%, data not shown), yet all
satellite cells transfected with the Pax-7 expression vector
have undetectable MyoD protein (Fig. 6D). Thus, over-
expression of Pax-7 in satellite cells on intact myofibers and
in myogenic cell lines consistently down-regulates MyoD,
prevents myogenin induction, and induces exit from the cell
cycle, a state that mimics quiescent adult satellite cells in
normal muscle tissue.
Forced down-regulation of Pax-7 neither induces myogenin
in proliferating MM14 myoblasts nor interferes with
myogenin induction upon differentiation
Up-regulation of Pax-7 appears to inhibit both MyoD and
myogenin expression and function and promotes cell cycle
exit, inducing a mitotically quiescent, undifferentiated state.
In addition, Pax-7 and myogenin proteins appear mutuallyexclusive in muscle cell lines and satellite cells. As elevated
levels of Pax-7 appear associated with the prevention of
differentiation, we asked if loss of Pax-7 promoted differ-
entiation or affected the kinetics of differentiation. To
accomplish this, we used a small interfering RNA
(siRNA)-based approach to reduce the levels of Pax-7
protein in proliferating MM14 cells, which will normally
express uniform levels of Pax-7. If the siRNA-induced loss
of Pax-7 promotes myogenesis, muscle cells would be
forced to exit the cell cycle and differentiate, inducing
myogenin and down-regulating Pax-7. As we would not be
able to distinguish between loss of Pax-7 occurring during
normal differentiation or as a result of siRNA transfection,
the ability of the siRNAs to reduce Pax-7 was initially tested
in 10T1/2 cells ectopically expressing Pax-7. Cultures of
10T1/2 cells transfected with constant levels of a Pax-7
expression vector, a control siRNA, four different Pax-7
siRNAs, and the pool of all four Pax-7 siRNAs were
harvested and the level of Pax-7 present determined by
Western blot analysis. All of the Pax-7 siRNAs reduced Pax-
7 protein levels in 10T1/2 cells expressing ectopic Pax-7
with two of them (D2 and D3) and the pooled siRNAs
substantially reducing Pax-7 protein (Fig. 7A). These data
confirm that these siRNAs are capable of reducing or
eliminating Pax-7 protein expression. MM14 cells were co-
transfected with the pooled siRNAs and a h-galactosidase
expression vector to mark transfected cells, cultured for 48 h,
and either grown or induced to differentiate for an additional
24 h. Immunofluorescence analysis reveals that transfected
cells (h-galactosidase-positive) fail to detectably express
Pax-7, while in cells transfected with a control siRNA, Pax-7
is clearly present (Fig. 7B). When siRNA-transfected cells
were examined for precocious induction of myogenin
protein, we found no apparent differences between control
and Pax-7 siRNA-transfected cells (Fig. 7C, upper panel).
Similarly, siRNA-mediated reduction of Pax-7 in differ-
entiated cultures had no apparent effect on cell morphology,
myogenin expression and localization, or the kinetics of
differentiation when compared to control siRNA transfected
cells (Fig. 7C, lower panel). Thus, the loss of Pax-7 protein
in MM14 cells does not appear to either induce differ-
entiation or affect the endogenous differentiation program,
suggesting that the proposed role for Pax-7 during satellite
cell renewal may be transient, functioning in a subset of the
activated satellite cell population. These results are consis-
tent with the described Pax-7/ phenotypes where muscle
formation appears to be normal despite the absence of
satellite cells.Discussion
Skeletal muscle regeneration requires the activation and
proliferation of muscle satellite cells, which eventually fuse
into preexisting myofibers, or fuse to form new myofibers
repairing muscle damage (Schultz and McCormick, 1994).
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Fig. 7. Forced down-regulation of Pax-7 has no effect on myogenin induction. (A) Pax-7 was overexpressed in 10T1/2 cells in the presence of a control
luciferase targeting oligonucleotide (ctrl), different siRNAs that target specific regions of the Pax-7 mRNA (D1–D4), or the four pooled siRNAs (pool). After
48 h, whole cell lysates were collected and Pax-7 protein was detected by Western blot. An approximately 70% reduction in Pax-7 expression was observed
when the pool of siRNAs was used. (B) Transfection with pooled siRNAs down-regulates Pax-7 in MM14 cells. The control siRNA has no detectable effect on
Pax-7 levels (lower panel, yellow arrows), while Pax-7 is greatly reduced or nondetectable in pool transfected MM14 cells (upper panel, white arrows). (C)
Pax-7 down-regulation does not promote precocious myogenin induction in proliferating myoblasts. Proliferating MM14 cells transfected with the pooled Pax-
7 siRNAs fail to up-regulate myogenin protein 24 h after transfection (upper panel, white arrows). Following induction of differentiation for 24 h, the timing of
appearance and localization of myogenin is indistinguishable from control siRNA-transfected cells (lower panel, white arrows). Scale bar = 12 Am.
H.C. Olguin, B.B. Olwin / Developmental Biology 275 (2004) 375–388 385Whether existing satellite cells are capable of self-renewal,
or as yet an uncharacterized stem cell pool replenishes the
satellite cell compartment is unknown and a subject of
current controversy (Angello and Hauschka, 1996; Hawke
and Garry, 2001; Schultz and McCormick, 1994; Seale and
Rudnicki, 2000). The paired box transcription factor Pax-7
has been postulated to be necessary for satellite cellFig. 6. Pax-7 overexpression induces cell cycle exit. (A) Twenty-four hours after tr
BrdU for 1 h before fixation. Pax-7-overexpressing cells (Pax-7ovxp) show m
compared to control cells. (B) Quantification of staining described in A shows a r
overexpression. (A total of 105 and 142 cells were counted for each of two indepen
in the presence of araC (for 6 days and 72 h, respectively). Cells were fixed and
positive and Pax-7-negative and either present in myotubes or as mononucleated
(yellow arrows). (D) Satellite cells on intact myofibers expressing ectopic Pax-7 d
were either co-transfected with h-galactosidase and Pax-7 expression vectors (Pax
for an additional 48 h and stained for h-galactosidase and MyoD. Myofiber-asso
detectable MyoD protein (Pax-7ovxp), whereas two distinct myofibers transfecte
MyoD and h-galactosidase protein (control). Scale bar = 12 Am.specification, based on dramatically reduced numbers of
satellite cells in Pax-7/ mice (Seale et al., 2000). Whether
Pax-7 is required only for specification of satellite cells
during development or whether Pax-7 is involved in skeletal
muscle regeneration is not yet known. Although Pax-7
mRNA appears to be present in all satellite cells (Seale et al.,
2000), we observed that Pax-7 protein levels are highlyansfection with a Pax-7 expression vector, MM14 cells were incubated with
arkedly reduced or nondetectable staining for BrdU (yellow arrowheads)
eduction of an approximately 80% in BrdU incorporation induced by Pax-7
dent experiments). (C) C2C12 and MM14 cells were induced to differentiate
stained for Pax-7 and myogenin. The majority of nuclei were myogenin-
cells. A subpopulation of cells was Pax-7 positive and myogenin negative
own-regulate MyoD. Intact myofiber cultures isolated and cultured for 24 h
-7ovxp), or h-galactosidase and an empty pcDNA vector (control), cultured
ciated satellite cells transfected with the Pax-7 expression vector have no
d with the pcDNA plasmid possess satellite cells that are positive for both
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activated and proliferating satellite cells. A similar degree of
heterogeneity was seen in proliferating C2C12 cells yet
Pax-7 protein levels in proliferating MM14 cells appeared
relatively homogeneous. The degree of Pax-7 heterogeneity
in satellite cells and C2C12 cells was unexpectedly large
with Pax-7 protein undetectable in some cells and at
apparently high levels in others. This heterogeneity did not
appear to be dependent on the cell lineage as a similar degree
of Pax-7 heterogeneity was observed both within and among
cell clones. We found these results surprising, given the
presumed requirement of Pax-7 for satellite cell specification
and surmised that Pax-7 may also play a functional role in
regulating satellite cell proliferation and differentiation.
Pax-7 and regulation of myogenesis
Despite the variations in Pax-7 levels in proliferating
satellite cells and satellite cell-derived cell lines, all
myogenic cells expressing myogenin were consistently
Pax-7 negative, supporting the conclusion that expression
of Pax-7 and myogenin is mutually exclusive. Loss of Pax-7
likely occurs as myogenin is induced since both mono-
nucleated and multinucleated myogenin-positive cells were
Pax-7 negative. Consistent with this observation, we found
that ectopic expression of Pax-7 prevented myogenic differ-
entiation and the induction of myogenin protein. Unexpect-
edly, we also observed that MyoD was down-regulated in
cells expressing high levels of Pax-7. Thus, Pax-7 appears to
function as an inhibitor of MyoD and myogenin, preventing
the expression of either protein in cells overexpressing Pax-
7. If Pax-7 is preventing MyoD function directly via
regulation of MyoD protein levels, then we would predict
that ectopically expressed Pax-7 would down-regulate
MyoD. The 10T1/2 cells, which readily commit to muscle
differentiation when MyoD is ectopically expressed (Davis
et al., 1987; Weintraub et al., 1989), fail to undergo
myogenesis when Pax-7 is ectopically expressed with
MyoD. Since MyoD protein is present, it is thus possible
that Pax-7 inhibition of MyoD function occurs indirectly via
changes in subcellular localization of MyoD or by inhibiting
MyoD-dependent transcription. Co-expression of a Pax-7
encoding plasmid at a twofold molar excess over a MyoD
plasmid completely eliminated both the ability of MyoD to
induce myogenesis and transcription from a MyoD-depend-
ent promoter, yet the subcellular localization of MyoD was
unaffected. Therefore, Pax-7 appears to block MyoD
function by preventing induction of MyoD-dependent
muscle gene expression. Notably, high levels of Pax-7
appeared to reduce the levels of MyoD in 10T1/2 cells
transfected with the highest amounts of plasmids encoding
Pax-7 (data not shown). Similar to other transcription factors,
MyoD has a short half-life and is degraded by an ubiquitin-
dependent pathway involving the proteosome (Abu Hatoum
et al., 1998). Since ubiquitin-mediated degradation of MyoD
is inhibited by the DNA target sequence for MyoD, and isdependent on the formation of MyoDd DNA complexes
(Abu Hatoum et al., 1998), it is tempting to speculate that
high levels of Pax-7 impair MyoD binding to its DNA target
sequences. However, the inability of Pax-7 to overcome the
effects of the MyoDE47 tethered dimer suggest that the
inhibition of MyoD may not involve competition for MyoD-
binding sites on DNA but could involve competition for
proteins necessary for MyoD-dependent transcription. Thus,
Pax-7-mediated inhibition of MyoDd DNA complex forma-
tion could account for the failure of MyoD to activate
muscle-specific reporters as well as the loss of MyoD
protein. This hypothesis requires that the absolute levels of
Pax-7 protein are critical; in most myoblasts, Pax-7 and
MyoD are both present, with typically low levels of Pax-7. In
agreement with this idea, untransfected satellite cells and
C2C12 cells with the highest levels of Pax-7 typically have
low or undetectable levels of MyoD protein (not shown).
Although quiescent satellite cells do not detectably express
myogenic transcription factors (Cornelison and Wold, 1997),
proliferating satellite cells, primary myoblasts, and skeletal
muscle cell lines typically express either myf-5, MyoD, or
both. Therefore, we asked if high levels of Pax-7 protein
affected proliferation of these cells.
Pax-7 and satellite cell self-renewal
In addition to inhibition and down-regulation of MyoD,
overexpression of Pax-7 reduced BrdU incorporation into
DNA by at least 80%, compared to myoblasts that express
endogenous levels of Pax-7. The high levels of Pax-7
expressed could artifactually affect MyoD function and not
represent an event occurring in normal satellite cells.
However, we and others have consistently observed a small
number of myogenin-negative mononucleated cells present
in cultures of C2C12 cells and primary satellite cells
subjected to long-term differentiation conditions (unpub-
lished data). We observed that these cells express very high
levels of Pax-7 compared to myoblasts in asynchronously
proliferating cultures. A similar population of cells have
been named breserveQ cells and are capable of providing
differentiated myotubes and additional reserve cells upon
subsequent replating (Yoshida et al., 1998). These breserveQ
cells exhibit other characteristics consistent with a self-
renewing population of skeletal muscle satellite cells. They
appear to cycle slowly as they are resistant to araC treatment
(Yoshida et al., 1998). When both MM14 and C2C12 cells
are maintained under differentiation conditions for extended
periods and treated with araC, a small population of
myogenin-negative cells remain that express very high levels
of Pax-7. These cells bear a striking resemblance to normal
resident satellite cells, as they are mitotically quiescent and
do not appear to express MyoD family members.
We have formulated a model that incorporates a require-
ment of Pax-7 for satellite cell biogenesis but not for
satellite cell specification per se (Fig 8). We postulate that
one mechanism that could allow for satellite cell self-
Fig. 8. Working model for the role of Pax-7 in satellite cell physiology. Mitotically quiescent satellite cells (yellow cell on myofiber) express a subset of
characteristic proteins including the markers syndecan-3, syndecan-4, and c-met but are heterogeneous for Pax-7 protein. Upon activation, satellite cells
proliferate and up-regulate MyoD. Proliferating myoblasts that are positive for both Pax-7 and MyoD (blue cells) behave as a heterogeneous population where a
small fraction of cells are prone to precocious differentiation inducing myogenin and losing Pax-7 expression (orange cells/blue nuclei) while a small number
retain precursor characteristics (blue cell/green nucleus). Co-expression of Pax-7 and MyoD might be required to retain myoblasts in a proliferative state and
prevent premature differentiation. As the myogenic program proceeds, MyoD family transcription factors are up-regulated and Pax-7 is down-regulated in cells
committed to differentiation (orange cells/blue nuclei). A small number of precursor cells (blue cell/green nucleus) up-regulate Pax-7 and down-regulate
MyoD, exit the cell cycle, and form a new satellite cell pool (yellow cell on myofiber). Additional events might be involved to evade apoptosis and acquire the
final satellite cell position beneath the basal lamina of regenerated muscle fibers.
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prediction of our model is that the satellite cells require Pax-
7 to down-regulate MyoD and become quiescent. It is not
yet understood what regulates the insertion of the satellite
cell between the basal lamina of the muscle fiber and the
fiber itself. Future experiments are aimed at further testing
this model and identifying the molecular mechanisms
regulating Pax-7 expression and Pax-7-mediated regulation
of MyoD.
A great deal of controversy has arisen recently regarding
the lineal origin of satellite cells and their capability for self-
renewal. Although not inconsistent with our model, several
groups postulate that satellite cells arise from lineages other
than skeletal muscle (Dreyfus et al., 2004; Goldring et al.,
2002; LaBarge and Blau, 2002; Seale and Rudnicki, 2000),
yet the frequency of external cell participation in muscle
formation and satellite cell replenishment is extremely rare
and thus inconsistent with a primary role in muscle
regeneration. Our work presented here provides a possible
mechanism involving Pax-7 that allow satellite cells to exit
the cell cycle, down-regulate MyoD, and prevent myogenininduction, phenotypes characteristic of the quiescent satellite
cell. Thus, it may be possible for satellite cells to self-renew
from cycling myoblasts or a subpopulation of satellite cells.Acknowledgments
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